Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Topelia logo — Topelia is developing and commercialising its proprietary An...

Topelia

Topelia is developing and commercialising its proprietary Antiviral Triple Therapy (ATT) TPL1 for coronavirus infection.

Founded 2021 Australia Australia 1 employees Health Care, Health and Wellness +1

General Information

Company Name Topelia
Founded Year 2021
Location Australia Australia +1
Employees 1
Industries Health Care, Health and Wellness, Sports
Social

Get notified when Topelia moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Topelia

Topelia is a biotechnology startup focused on developing and commercializing its proprietary Antiviral Triple Therapy (ATT), TPL101, initially targeted at treating COVID-19 infections. The company's leadership, with a successful track record in commercializing a Triple Therapy for Helicobacter pylori, is now leveraging their expertise to develop TPL101. This therapy aims to enhance current COVID-19 strategies by offering a safe antiviral option alongside vaccines and authorized antiviral treatments in response to increasing vaccine hesitancy and declining interest in current antiviral options. TPL101 combines ivermectin and doxycycline, with the addition of zinc in a proprietary fixed-dose combination. The use of known, regulator-approved APIs in the development process promises to be faster, more cost-effective, and lower risk. Topelia is on track to conduct its Phase 3 trial and plans to seek TGA approval in CY2025. The startup plans to investigate TPL101’s effectiveness against other respiratory viral infections, including Avian influenza and diseases caused by the Flaviviridae family. With the company's focus on tackling broader range of viral infections, Topelia presents an intriguing investment opportunity in the Health Care, Health and Wellness, and Sports industries. For more information, visit their website at www.topeliaaustralia.com.

Taxonomy: Infectious Disease, Antiviral Therapeutics, Fixed Dose Combination, Clinical Trials, Respiratory Viral Infections, High Growth Biotech

No funding data available for Topelia yet.

Get notified when Topelia raises funding

Topelia Alternatives & Competitors

Topelia vs
ViroCarb Inc.
ViroCarb Inc. Canada

Antiviral company with a paradigm shift drug platform that provides broad-spectrum protection agains...

Non Equity Assistance
4 employees
Biotechnology
Topelia vs
Replicor Inc.
Replicor Inc. Canada

292 million people have chronic hepatitis B. We're developing the cure.

6 employees
Biotechnology, Health Care
Topelia vs
Okapi Sciences
Okapi Sciences

Enhancing leadership in pet therapeutics with high value antiviral drugs and strong academic partner...

Grant
Biotechnology, Health and Wellness

FAQ About Topelia

Topelia is developing and commercialising its proprietary Antiviral Triple Therapy (ATT) TPL1 for coronavirus infection.
Topelia was founded in 2021.
Topelia is headquartered in Australia.
Topelia operates in the following industries: Health Care, Health and Wellness, Sports.
Topelia has approximately 1 employees.
Top alternatives and competitors to Topelia include ViroCarb Inc., Replicor Inc., Okapi Sciences, SyneuRx International (Taiwan) Corp., For-Robin, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Topelia and ViroCarb Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Topelia and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy